Reduced trunk fat and triglycerides after strength training are associated with reduced LPS levels in HIV-infected individuals

Journal of Acquired Immune Deficiency Syndromes

Volumn 66, Issue 2, 2014, Pages

  Trøseid, Marius ^a   Ditlevsen, Susanne ^b   Hvid, Tine ^b,c   Gerstoft, Jan ^c   Grøndahl, Thomas ^b,c   Pedersen, Bente Klarlund ^b,c   Nielsen, Susanne D ^b   Lindegaard, Birgitte ^b,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LIPOPOLYSACCHARIDE; TRIACYLGLYCEROL;

BODY FAT; CARDIOVASCULAR RISK; FAT BODY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LIPID COMPOSITION; LIPODYSTROPHY; MICROBIAL ACTIVITY; MORTALITY; PRIORITY JOURNAL; RESISTANCE TRAINING; TRUNK;

HIV INFECTIONS; HUMANS; INTRA-ABDOMINAL FAT; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; RESISTANCE TRAINING; TRIGLYCERIDES;

EID: 84901507730     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000132     Document Type: Letter

References (19)

1. Smith C, Sabin CA, Lundgren JD, et al. Factors associated with specific causes of death amongst HIV-positive individuals in the D: A:D Study. AIDS. 2010;24:1537-1548.
2. Sandler NG, Douek DC. Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nat Rev Microbiol. 2012;10:655-666.
3. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365-1371. (Pubitemid 44924494)
4. Rajasuriar R, Booth D, Solomon A, et al. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor alpha and microbial translocation. J Infect Dis. 2010;202: 1254-1264.
5. Troseid M, Nowak P, Nystrom J, et al. Elevated plasma levels of lipopolysaccharide and high mobility group box-1 protein are associated with high viral load in HIV-1 infection: reduction by 2-year antiretroviral therapy. AIDS. 2010;24:1733-1737.
6. Wallet MA, Rodriguez CA, Yin L, et al. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy. AIDS. 2010;24:1281-1290.
7. Funderburg NT, Mayne E, Sieg SF, et al. Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. Blood. 2010;115:161-167.
8. Haugaard AK, Lund TT, Birch C, et al. Discrepant coagulation profile in HIV infection: elevated D-dimer but impaired platelet aggregation and clot initiation. AIDS. 2013; 27:2749-2758.
9. Manner I, Baekken M, Kvale D, et al. Markers of microbial translocation predict hypertension in HIV-infected individuals. HIV Med. 2013;14:354-361.
10. Pedersen KK, Pedersen M, Troseid M, et al. Microbial translocation in HIV infection is associated with dyslipidemia, insulin resistance, and risk of myocardial infarction. J Acquir Immune Defic Syndr. 2013;64:425-433.
11. Timmons T, Shen C, Aldrovandi G, et al. Microbial translocation and metabolic and body composition measures in treated and untreated HIV infection. AIDS Res Hum Retroviruses. 2013;30:272-277.
12. Lindegaard B, Hansen T, Hvid T, et al. The effect of strength and endurance training on insulin sensitivity and fat distribution in human immunodeficiency virus-infected patients with lipodystrophy. J Clin Endocrinol Metab. 2008;93:3860-3869.
13. Troseid M, Nestvold TK, Rudi K, et al. Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: evidence from bariatric surgery. Diabetes Care. 2013;36:3627-3632.
14. Ghoshal S, Witta J, Zhong J, et al. Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res. 2009;50:90-97.
15. Kallio KA, Buhlin K, Jauhiainen M, et al. Lipopolysaccharide associates with proatherogenic lipoproteins in periodontitis patients. Innate Immun. 2008;14:247-253.
16. Levine DM, Parker TS, Donnelly TM, et al. In vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci U S A. 1993;90:12040-12044. (Pubitemid 24008776)
17. Feingold KR, Staprans I, Memon RA, et al. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res. 1992;33:1765-1776. (Pubitemid 23006653)
18. Casanovas A, Carrascal M, Abian J, et al. Lipoprotein lipase is nitrated in vivo after lipopolysaccharide challenge. Free Radic Biol Med. 2009;47:1553-1560.
19. Yao-Borengasser A, Varma V, Coker RH, et al. Adipose triglyceride lipase expression in human adipose tissue and muscle. Role in insulin resistance and response to training and pioglitazone. Metabolism 2011;60:1012-1020.